41 66 (38) Finance Cost 6 8 (25) Net Profit 51 38 34 (Unit : Million Baht) Financial statements in which the equity method is applied Q3/2018 Q3/2017 % Change Sales and Service income 462 514 (10) Cost

% 150.00 1.03% 12.68 8.45% Selling and administrative expenses 2,693.23 17.89% 2,709.73 18.63% (16.51) (0.61%) Profit before finance cost and income tax expenses 1,797.48 11.94% 1,661.18 11.42% 136.30 8.20

exchange loss - - - 61.0 - 100.0 Finance costs 7.0 4.3 63.2 17.3 13.8 25.4 Total expenses 333.6 450.0 (25.9) 981.1 1,335.1 (26.5) 3rd Quarter 2020  Cost of Goods Sold Total cost of goods sold presented at

the Extraordinary General Meeting of Shareholders No. 1/2018 considers and approves the amendments to the Company’s Articles of Association in Article 10 regarding the issuance and transfer of shares

and approves the amendments to the Company’s Articles of Association in Article 10 regarding the issuance and transfer of shares, Article 27 regarding the board of directors’ meeting and Article 36

(Mrs.Poeng-lada Phalakornkul ) Common Share 20/12/2018 1,500,000 - Transfer Link VIBHAVADI MEDICAL CENTER PUBLIC COMPANY LIMITED (VIBHA) Major General SURIYA PHALAKORNKUL Spouse / Cohabiting Couple (Mrs.Poeng

10.6% 25.1% 3,862.1 4,766.5 23.4% Revenue from finance lease under power purchase agreement 104.9 95.3 109.4 14.8% 4.3% 305.7 307.0 0.4% Cost of sales and services (971.2) (1,174.0) (1,350.7) 15.1% 39.1

ESSE Asoke’ (77% sales progress, tentative transfer in December 2018), ‘The ESSE at Singha Complex’ (91% sales progress, tentative transfer in 3Q19), and ‘The ESSE Sukhumvit 36’ (52% sales progress

) dated 19 September 2003 (including the amendments thereof) (“Notifications on Connected Transactions”). The Company speculates that the payment of shares and the transfer of the ordinary shares of KPN

registration statement neither represents that the Ministry of Finance of Thailand, the Securities and Exchange Commission or the Office of the Securities and Exchange Commission have suggested investment in the